BIOMARIN PHARMACEUTICAL INC Selling, General and Administrative Expense
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Selling, General and Administrative Expense of $395.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for the quarter ending 2026-06-30 was $395.55M, a 70.29% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for the quarter ending 2026-03-31 was $258.29M, a 25.31% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for the quarter ending 2025-12-31 was $446.21M, a 67.37% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for the quarter ending 2025-09-30 was $268.42M, a 5.89% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for fiscal 2025 was $1.15B, a 14.27% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for fiscal 2024 was $1.01B, a 13.07% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for fiscal 2023 was $892.41M, a 8.40% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC selling, general and administrative expense for fiscal 2022 was $823.24M, a 8.41% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $395.55M 10-Q · filed 2026-08-06 | $653.84M 10-Q · filed 2026-08-06 | $1.10B derived: sum of 3 quarters · filed 2026-08-06 | $1.37B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $258.29M 10-Q · filed 2026-05-05 | $704.50M derived: sum of 2 quarters · filed 2026-05-05 | $972.91M derived: sum of 3 quarters · filed 2026-05-05 | $1.21B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $446.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $714.62M derived: sum of 2 quarters · filed 2026-02-26 | $946.90M derived: sum of 3 quarters · filed 2026-08-06 | $1.15B 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $268.42M 10-Q · filed 2025-10-28 | $500.69M derived: sum of 2 quarters · filed 2026-08-06 | $706.81M 10-Q · filed 2025-10-28 | $973.42M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $232.28M 10-Q · filed 2026-08-06 | $438.39M 10-Q · filed 2026-08-06 | $705.00M derived: sum of 3 quarters · filed 2026-08-06 | $958.48M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $206.12M 10-Q · filed 2026-05-05 | $472.72M derived: sum of 2 quarters · filed 2026-05-05 | $726.20M derived: sum of 3 quarters · filed 2026-05-05 | $989.24M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $266.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $520.09M derived: sum of 2 quarters · filed 2026-02-26 | $783.12M derived: sum of 3 quarters · filed 2026-02-26 | $1.01B 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $253.48M 10-Q · filed 2025-10-28 | $516.51M derived: sum of 2 quarters · filed 2025-10-28 | $742.42M 10-Q · filed 2025-10-28 | $1.00B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $263.03M 10-Q · filed 2025-08-05 | $488.94M 10-Q · filed 2025-08-05 | $748.45M derived: sum of 3 quarters · filed 2026-02-26 | $964.22M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $225.91M 10-Q · filed 2025-05-02 | $485.42M derived: sum of 2 quarters · filed 2026-02-26 | $701.19M derived: sum of 3 quarters · filed 2026-02-26 | $907.29M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $259.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $475.28M derived: sum of 2 quarters · filed 2026-02-26 | $681.38M derived: sum of 3 quarters · filed 2026-02-26 | $892.41M 10-K · filed 2026-02-26 | $937.29M 10-K · filed 2024-02-26 | |||
| 2023-09-30 | $215.77M 10-Q · filed 2024-10-31 | $223.93M 10-Q · filed 2023-11-02 | $421.87M derived: sum of 2 quarters · filed 2024-10-31 | $632.89M 10-Q · filed 2024-10-31 | $662.27M 10-Q · filed 2023-11-02 | $847.87M derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-06-30 | $206.10M 10-Q · filed 2024-08-05 | $215.34M 10-Q · filed 2023-08-02 | $417.13M 10-Q · filed 2024-08-05 | $438.34M 10-Q · filed 2023-08-02 | $632.10M derived: sum of 3 quarters · filed 2025-02-24 | $848.91M derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-03-31 | $211.02M 10-Q · filed 2024-04-26 | $223.00M 10-Q · filed 2023-04-28 | $426.00M derived: sum of 2 quarters · filed 2025-02-24 | $642.81M derived: sum of 3 quarters · filed 2025-02-24 | $839.65M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-12-31 | $214.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $431.79M derived: sum of 2 quarters · filed 2025-02-24 | $628.62M derived: sum of 3 quarters · filed 2025-02-24 | $823.24M 10-K · filed 2025-02-24 | $854.01M 10-K · filed 2023-02-27 | |||
| 2022-09-30 | $216.82M 10-Q · filed 2023-11-02 | $413.65M derived: sum of 2 quarters · filed 2023-11-02 | $608.27M 10-Q · filed 2023-11-02 | $825.83M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $196.84M 10-Q · filed 2023-08-02 | $391.45M 10-Q · filed 2023-08-02 | $609.02M derived: sum of 3 quarters · filed 2024-02-26 | $792.35M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $194.62M 10-Q · filed 2023-04-28 | $412.18M derived: sum of 2 quarters · filed 2024-02-26 | $595.51M derived: sum of 3 quarters · filed 2024-02-26 | $779.68M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $217.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $400.90M derived: sum of 2 quarters · filed 2024-02-26 | $585.06M derived: sum of 3 quarters · filed 2024-02-26 | $759.38M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $183.33M 10-Q · filed 2022-10-28 | $367.49M derived: sum of 2 quarters · filed 2022-10-28 | $541.81M 10-Q · filed 2022-10-28 | $737.32M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $184.16M 10-Q · filed 2022-08-04 | $358.48M 10-Q · filed 2022-08-04 | $553.99M derived: sum of 3 quarters · filed 2023-02-27 | $733.44M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $174.32M 10-Q · filed 2022-04-29 | $369.83M derived: sum of 2 quarters · filed 2023-02-27 | $549.28M derived: sum of 3 quarters · filed 2023-02-27 | $724.69M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $195.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $374.96M derived: sum of 2 quarters · filed 2023-02-27 | $550.37M derived: sum of 3 quarters · filed 2023-02-27 | $737.67M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $179.45M 10-Q · filed 2021-10-29 | $354.86M derived: sum of 2 quarters · filed 2021-10-29 | $542.16M 10-Q · filed 2021-10-29 | $730.06M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $175.41M 10-Q · filed 2021-07-30 | $362.71M 10-Q · filed 2021-07-30 | $550.61M derived: sum of 3 quarters · filed 2022-02-25 | $720.72M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $187.29M 10-Q · filed 2021-04-30 | $375.19M derived: sum of 2 quarters · filed 2022-02-25 | $545.31M derived: sum of 3 quarters · filed 2022-02-25 | $706.06M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $187.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $358.01M derived: sum of 2 quarters · filed 2022-02-25 | $518.77M derived: sum of 3 quarters · filed 2022-02-25 | $680.92M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $170.11M 10-Q · filed 2020-11-06 | $330.87M derived: sum of 2 quarters · filed 2020-11-06 | $493.02M 10-Q · filed 2020-11-06 | $657.20M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $160.75M 10-Q · filed 2020-08-05 | $322.91M 10-Q · filed 2020-08-05 | $487.08M derived: sum of 3 quarters · filed 2021-02-26 | $635.65M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $162.16M 10-Q · filed 2020-05-01 | $326.33M derived: sum of 2 quarters · filed 2021-02-26 | $474.89M derived: sum of 3 quarters · filed 2021-02-26 | $628.17M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $164.17M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $312.74M derived: sum of 2 quarters · filed 2021-02-26 | $466.02M derived: sum of 3 quarters · filed 2021-02-26 | $604.35M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $148.57M 10-Q/A · filed 2019-11-04 | $301.85M derived: sum of 2 quarters · filed 2019-11-04 | $440.18M 10-Q/A · filed 2019-11-04 | $600.46M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $153.28M 10-Q · filed 2019-08-02 | $291.62M 10-Q · filed 2019-08-02 | $451.90M derived: sum of 3 quarters · filed 2020-02-27 | $582.43M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $138.34M 10-Q · filed 2019-04-29 | $298.62M derived: sum of 2 quarters · filed 2020-02-27 | $429.15M derived: sum of 3 quarters · filed 2020-02-27 | $572.65M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $160.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $290.81M derived: sum of 2 quarters · filed 2020-02-27 | $434.32M derived: sum of 3 quarters · filed 2020-02-27 | $554.34M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $130.53M 10-Q · filed 2018-10-26 | $274.04M derived: sum of 2 quarters · filed 2018-10-26 | $394.06M 10-Q · filed 2018-10-26 | $537.01M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $143.50M 10-Q · filed 2018-08-03 | $263.52M 10-Q · filed 2018-08-03 | $406.48M derived: sum of 3 quarters · filed 2019-02-28 | $525.24M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $120.02M 10-Q · filed 2018-04-27 | $262.98M derived: sum of 2 quarters · filed 2019-02-28 | $381.74M derived: sum of 3 quarters · filed 2019-02-28 | $491.31M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $142.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $261.72M derived: sum of 2 quarters · filed 2019-02-28 | $371.29M derived: sum of 3 quarters · filed 2019-02-28 | $476.59M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $118.76M 10-Q · filed 2017-10-31 | $228.34M derived: sum of 2 quarters · filed 2017-10-31 | $333.63M 10-Q · filed 2017-10-31 | $447.54M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $109.58M 10-Q · filed 2017-08-02 | $214.88M 10-Q · filed 2017-08-02 | $328.78M derived: sum of 3 quarters · filed 2018-02-26 | $422.83M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $105.30M 10-Q · filed 2017-05-04 | $219.21M derived: sum of 2 quarters · filed 2018-02-26 | $313.25M derived: sum of 3 quarters · filed 2018-02-26 | $414.76M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $113.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $207.95M derived: sum of 2 quarters · filed 2018-02-26 | $309.46M derived: sum of 3 quarters · filed 2018-02-26 | $402.27M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $94.04M 10-Q · filed 2016-11-03 | $195.56M derived: sum of 2 quarters · filed 2016-11-03 | $288.36M 10-Q · filed 2016-11-03 | $388.13M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $101.51M 10-Q · filed 2016-08-08 | $194.32M 10-Q · filed 2016-08-08 | $294.09M derived: sum of 3 quarters · filed 2017-02-27 | $368.69M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $92.81M 10-Q · filed 2016-05-02 | $192.57M derived: sum of 2 quarters · filed 2017-02-27 | $267.18M derived: sum of 3 quarters · filed 2017-02-27 | $335.27M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $99.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $174.37M derived: sum of 2 quarters · filed 2017-02-27 | $242.46M derived: sum of 3 quarters · filed 2017-02-27 | $302.16M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $74.60M 10-Q · filed 2015-11-02 | $142.69M derived: sum of 2 quarters · filed 2015-11-02 | $202.39M 10-Q · filed 2015-11-02 | $202.52M 10-Q · filed 2014-10-28 | $274.57M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $68.09M 10-Q · filed 2015-08-05 | $128.16M 10-Q · filed 2015-08-05 | $199.97M derived: sum of 3 quarters · filed 2016-02-29 | $261.81M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $60.07M 10-Q · filed 2015-05-05 | $131.88M derived: sum of 2 quarters · filed 2016-02-29 | $193.72M derived: sum of 3 quarters · filed 2016-02-29 | $244.38M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $71.81M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $133.65M derived: sum of 2 quarters · filed 2016-02-29 | $184.31M derived: sum of 3 quarters · filed 2016-02-29 | $235.36M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $61.84M 10-Q · filed 2014-10-28 | $112.50M derived: sum of 2 quarters · filed 2014-10-28 | $163.55M 10-Q · filed 2014-10-28 | $218.60M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $50.66M 10-Q · filed 2014-07-31 | $101.71M 10-Q · filed 2014-07-31 | $156.75M derived: sum of 3 quarters · filed 2015-03-02 | $203.09M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $51.05M 10-Q · filed 2014-05-02 | $106.10M derived: sum of 2 quarters · filed 2015-03-02 | $152.44M derived: sum of 3 quarters · filed 2015-03-02 | $203.97M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $55.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $101.39M derived: sum of 2 quarters · filed 2015-03-02 | $152.93M derived: sum of 3 quarters · filed 2015-03-02 | $198.17M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $46.34M 10-Q · filed 2013-10-28 | $97.88M derived: sum of 2 quarters · filed 2013-10-28 | $143.12M 10-Q · filed 2013-10-28 | $191.58M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | $51.54M 10-Q · filed 2013-07-29 | $96.79M 10-Q · filed 2013-07-29 | $145.24M derived: sum of 3 quarters · filed 2014-02-26 | $190.12M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | $45.25M 10-Q · filed 2013-04-29 | $93.70M derived: sum of 2 quarters · filed 2014-02-26 | $138.58M derived: sum of 3 quarters · filed 2014-02-26 | $179.60M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | $48.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $93.33M derived: sum of 2 quarters · filed 2014-02-26 | $134.35M derived: sum of 3 quarters · filed 2014-02-26 | $175.42M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | $44.88M 10-Q · filed 2012-10-29 | $85.89M derived: sum of 2 quarters · filed 2012-10-29 | $126.97M 10-Q · filed 2012-10-29 | $169.03M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $41.02M 10-Q · filed 2012-08-02 | $82.09M 10-Q · filed 2012-08-02 | $124.15M derived: sum of 3 quarters · filed 2013-02-26 | $162.50M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $41.04M 10-Q · filed 2012-04-30 | $83.14M derived: sum of 2 quarters · filed 2013-02-26 | $121.48M derived: sum of 3 quarters · filed 2013-02-26 | $158.76M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $42.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $80.45M derived: sum of 2 quarters · filed 2013-02-26 | $117.72M derived: sum of 3 quarters · filed 2013-02-26 | $151.72M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $38.35M 10-Q · filed 2011-10-31 | $75.63M derived: sum of 2 quarters · filed 2011-10-31 | $109.63M 10-Q · filed 2011-10-31 | $146.15M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $37.28M 10-Q · filed 2011-08-01 | $71.28M 10-Q · filed 2011-08-01 | $107.81M derived: sum of 3 quarters · filed 2012-02-22 | $136.47M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $34.00M 10-Q · filed 2011-04-29 | $70.53M derived: sum of 2 quarters · filed 2012-02-22 | $99.19M derived: sum of 3 quarters · filed 2012-02-22 | $129.72M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $36.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $65.19M derived: sum of 2 quarters · filed 2012-02-22 | $95.72M derived: sum of 3 quarters · filed 2012-02-22 | $124.29M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $28.67M 10-Q · filed 2010-10-29 | $59.19M derived: sum of 2 quarters · filed 2010-10-29 | $87.76M 10-Q · filed 2010-10-29 | |||||
| 2009-06-30 | $30.53M 10-Q · filed 2010-08-04 | $59.09M 10-Q · filed 2010-08-04 | ||||||
| 2008-12-31 | $106.57M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |